Corstasis Therapeutics logo

Corstasis Therapeutics

Advancing Options for Patients Suffering from Edema Associated with Congestive Heart Failure, Liver, and Kidney Disease

10 employees · est. 2018 · Henderson, United States

VS
Sequana Medical NV logo

Sequana Medical NV

Pioneers in the treatment of drug-resistant fluid overload in liver disease, heart failure and cancer

37 employees · est. 2006 · Zwijnaarde, Belgium

Sequana Medical NV is the older company (2018 vs 2006); Sequana Medical NV is the larger of the two.

Side-by-Side Comparison

Corstasis Therapeutics Sequana Medical NV
Founded
2018 2006 older
Headquarters
Henderson, United States Zwijnaarde, Belgium
Employees
10 37 larger
Industry
Not tracked yet Biotechnology, Health Care, Manufacturing
Funding Stage
Unknown Post Ipo Equity
Total Funding
Not tracked yet $123.48M
Funding Rounds
1 11
Services
Intuitive outpatient therapeutic options, Fluid overload reduction Not tracked yet
Target Customers
Patients with congestive heart failure, Patients with liver disease, Patients with kidney disease, Home healthcare providers Not tracked yet
Taxonomy
Pharmaceutical Innovation, Outpatient Treatment, Edema Solutions, Congestive Heart Failure, Liver Disease, Kidney Disease, Cardiology, Nephrology, Heart Failure Management, Clinical Stage Company, Fluid Overload Medical Device Company, Implantable Pump Systems, Fluid Balance Management, Ascites Management, Chronic Liver Disease, Congestive Heart Failure, Cancer Treatment, Drug-resistant Fluid Overload, Euronext Brussels Listed Company, Alfapump System, DSR® Technology, Quality Of Life Improvement, Healthcare Cost Reduction, Swiss Medical Technology
Website
corstasis.com sequanamedical.com
Corstasis Therapeutics logo

About Corstasis Therapeutics

Corstasis Therapeutics, founded in 2018, is a clinical-stage pharmaceutical company based in the United States. The firm is focused on advancing innovative outpatient options for patients grappling with fluid overload, or edema, which is commonly associated with conditions like congestive heart fail...

Sequana Medical NV logo

About Sequana Medical NV

Sequana Medical NV is a pioneer in treating drug-resistant fluid overload, a serious and frequent clinical complication in patients with liver disease, heart failure and cancer. Fluid overload is a well-recognized problem in these growing diseases, causing severe problems for the large number of...

We will tell you when either one moves

BounceWatch watches Corstasis Therapeutics and Sequana Medical NV for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Corstasis Therapeutics and Sequana Medical NV — by email.

Frequently Asked Questions

Corstasis Therapeutics — Advancing Options for Patients Suffering from Edema Associated with Congestive Heart Failure, Liver, and Kidney Disease. Sequana Medical NV — Pioneers in the treatment of drug-resistant fluid overload in liver disease, heart failure and cancer. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Corstasis Therapeutics has raised undisclosed funding while Sequana Medical NV has raised $123.48M.
Corstasis Therapeutics and Sequana Medical NV operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Corstasis Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Corstasis Therapeutics on 3 Mar 2026, and Sequana Medical NV on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes